Status:
UNKNOWN
Impact of Customized Respiratory Training on Cardiopulmonary Function in Parkison's Disease
Lead Sponsor:
University of St. Augustine for Health Sciences
Conditions:
Parkinson Disease
Eligibility:
All Genders
30-99 years
Phase:
NA
Brief Summary
People with PD have lower cardiopulmonary function than their age matched peers. This decline can further impair a person's ability to participate in exercise and daily activities. Furthermore, the l...
Detailed Description
Testers will complete the following outcome measures at the pretest: height, weight, maximum inspiratory pressure, maximum expiratory pressure, heart rate, blood pressure, respiratory rate, six-minute...
Eligibility Criteria
Inclusion
- physician's diagnosis of Parkinson's disease
Exclusion
- people who are actively smoking, have a pacemaker, recent diagnosis of chronic obstructive pulmonary disease, bronchial asthma, active pulmonary disease within 1 month, or hospitalization within 2 months of time of study
Key Trial Info
Start Date :
November 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05287243
Start Date
November 1 2022
End Date
December 1 2023
Last Update
May 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of St. Augustine for Health Sciences
Austin, Texas, United States, 78739